This observational study is following people with Post Stroke Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States

DepressionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Duke University
Condition: Depression

View study

RecruitingNCT06704594

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Mental health

View study

RecruitingNCT04135846

Alpha-1 Blockade for Addiction (AUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Brown University
Condition: Addiction

View study

RecruitingNCT05915013

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

This study is comparing Ketamine with placebo for people with major depression or PTSD. Participants receive Ketamine or placebo and complete study visits and assessments.

In United States

PTSD, DepressionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Yale University
Condition: PTSD, Depression

View study

RecruitingNCT02916810

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.

In United States

SchizophreniaDeviceFrom 18 Years to 50 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Schizophrenia

View study

RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Alto Neuroscience
Condition: Bipolarity, Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.